HEADER PROTON TRANSPORT 16-APR-22 7XJD TITLE CRYSTAL STRUCTURE OF BACTERIORHODOPSIN IN THE GROUND STATE BY RED TITLE 2 LASER IRRADIATION CAVEAT 7XJD L2P A 302 HAS WRONG CHIRALITY AT ATOM C2 L2P A 302 HAS WRONG CAVEAT 2 7XJD CHIRALITY AT ATOM C18 L2P A 302 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 7XJD C23 L2P A 302 HAS WRONG CHIRALITY AT ATOM C43 L2P A 302 HAS CAVEAT 4 7XJD WRONG CHIRALITY AT ATOM C48 L2P A 303 HAS WRONG CHIRALITY CAVEAT 5 7XJD AT ATOM C2 L2P A 304 HAS WRONG CHIRALITY AT ATOM C18 L2P A CAVEAT 6 7XJD 304 HAS WRONG CHIRALITY AT ATOM C43 L2P A 305 HAS WRONG CAVEAT 7 7XJD CHIRALITY AT ATOM C2 L2P A 305 HAS WRONG CHIRALITY AT ATOM CAVEAT 8 7XJD C13 L2P A 305 HAS WRONG CHIRALITY AT ATOM C23 L2P A 305 HAS CAVEAT 9 7XJD WRONG CHIRALITY AT ATOM C43 L2P A 306 HAS WRONG CHIRALITY CAVEAT 10 7XJD AT ATOM C23 L2P A 306 HAS WRONG CHIRALITY AT ATOM C43 L2P A CAVEAT 11 7XJD 306 HAS WRONG CHIRALITY AT ATOM C53 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACTERIORHODOPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BR,BACTERIOOPSIN,BO SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HALOBACTERIUM SALINARUM NRC-1; SOURCE 3 ORGANISM_TAXID: 64091; SOURCE 4 STRAIN: ATCC 700922 / JCM 11081 / NRC-1 KEYWDS PROTON PUMP, MEMBRANE PROTEIN, PROTON TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR S.TAGUCHI,S.NIWA,K.TAKEDA REVDAT 2 20-NOV-24 7XJD 1 REMARK REVDAT 1 22-MAR-23 7XJD 0 JRNL AUTH S.TAGUCHI,S.NIWA,H.A.DAO,Y.TANAKA,R.TAKEDA,S.FUKAI, JRNL AUTH 2 K.HASEGAWA,K.TAKEDA JRNL TITL DETAILED ANALYSIS OF DISTORTED RETINAL AND ITS INTERACTION JRNL TITL 2 WITH SURROUNDING RESIDUES IN THE K INTERMEDIATE OF JRNL TITL 3 BACTERIORHODOPSIN. JRNL REF COMMUN BIOL V. 6 190 2023 JRNL REFN ESSN 2399-3642 JRNL PMID 36808185 JRNL DOI 10.1038/S42003-023-04554-2 REMARK 2 REMARK 2 RESOLUTION. 1.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELX REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1779 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 394 REMARK 3 SOLVENT ATOMS : 58 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 ANGLE DISTANCES (A) : NULL REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7XJD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-APR-22. REMARK 100 THE DEPOSITION ID IS D_1300028945. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-OCT-20 REMARK 200 TEMPERATURE (KELVIN) : 15 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52290 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.330 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.807 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.0400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 1.16200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.330 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 5ZIL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MO, 2.0-2.5 M PHOSPHATE, PH 5.6, REMARK 280 LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 55.44500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 55.44500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 55.44500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 31720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -255.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 121.14000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 -104.91032 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 151.42500 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 52.45516 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 64 CB - CG - CD1 ANGL. DEV. = -4.0 DEGREES REMARK 500 ARG A 82 NE - CZ - NH2 ANGL. DEV. = -4.6 DEGREES REMARK 500 TYR A 131 CB - CG - CD2 ANGL. DEV. = -4.6 DEGREES REMARK 500 TYR A 131 CB - CG - CD1 ANGL. DEV. = 4.6 DEGREES REMARK 500 TYR A 133 CB - CG - CD2 ANGL. DEV. = -4.5 DEGREES REMARK 500 TYR A 133 CB - CG - CD1 ANGL. DEV. = 5.1 DEGREES REMARK 500 ARG A 225 CD - NE - CZ ANGL. DEV. = 11.9 DEGREES REMARK 500 ARG A 225 NE - CZ - NH1 ANGL. DEV. = 8.0 DEGREES REMARK 500 ARG A 225 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 ARG A 227 CD - NE - CZ ANGL. DEV. = 11.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 162 62.84 -107.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 544 DISTANCE = 7.07 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 L2P A 303 REMARK 610 L2P A 306 REMARK 610 SQU A 312 REMARK 610 L2P A 313 REMARK 610 L2P A 315 REMARK 610 L2P A 320 REMARK 610 L2P A 322 REMARK 610 L2P A 323 REMARK 610 L2P A 324 REMARK 610 L2P A 327 REMARK 610 L2P A 328 REMARK 610 L2P A 333 REMARK 610 SQU A 341 REMARK 610 SQU A 342 REMARK 610 SQU A 343 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7XJC RELATED DB: PDB REMARK 900 RELATED ID: 7XJE RELATED DB: PDB DBREF 7XJD A 5 234 UNP P02945 BACR_HALSA 18 247 SEQRES 1 A 230 THR GLY ARG PRO GLU TRP ILE TRP LEU ALA LEU GLY THR SEQRES 2 A 230 ALA LEU MET GLY LEU GLY THR LEU TYR PHE LEU VAL LYS SEQRES 3 A 230 GLY MET GLY VAL SER ASP PRO ASP ALA LYS LYS PHE TYR SEQRES 4 A 230 ALA ILE THR THR LEU VAL PRO ALA ILE ALA PHE THR MET SEQRES 5 A 230 TYR LEU SER MET LEU LEU GLY TYR GLY LEU THR MET VAL SEQRES 6 A 230 PRO PHE GLY GLY GLU GLN ASN PRO ILE TYR TRP ALA ARG SEQRES 7 A 230 TYR ALA ASP TRP LEU PHE THR THR PRO LEU LEU LEU LEU SEQRES 8 A 230 ASP LEU ALA LEU LEU VAL ASP ALA ASP GLN GLY THR ILE SEQRES 9 A 230 LEU ALA LEU VAL GLY ALA ASP GLY ILE MET ILE GLY THR SEQRES 10 A 230 GLY LEU VAL GLY ALA LEU THR LYS VAL TYR SER TYR ARG SEQRES 11 A 230 PHE VAL TRP TRP ALA ILE SER THR ALA ALA MET LEU TYR SEQRES 12 A 230 ILE LEU TYR VAL LEU PHE PHE GLY PHE THR SER LYS ALA SEQRES 13 A 230 GLU SER MET ARG PRO GLU VAL ALA SER THR PHE LYS VAL SEQRES 14 A 230 LEU ARG ASN VAL THR VAL VAL LEU TRP SER ALA TYR PRO SEQRES 15 A 230 VAL VAL TRP LEU ILE GLY SER GLU GLY ALA GLY ILE VAL SEQRES 16 A 230 PRO LEU ASN ILE GLU THR LEU LEU PHE MET VAL LEU ASP SEQRES 17 A 230 VAL SER ALA LYS VAL GLY PHE GLY LEU ILE LEU LEU ARG SEQRES 18 A 230 SER ARG ALA ILE PHE GLY GLU ALA GLU HET RET A 301 20 HET L2P A 302 46 HET L2P A 303 40 HET L2P A 304 46 HET L2P A 305 46 HET L2P A 306 42 HET SQU A 312 6 HET L2P A 313 17 HET L2P A 315 10 HET L2P A 320 26 HET L2P A 322 10 HET L2P A 323 10 HET L2P A 324 12 HET L2P A 327 10 HET L2P A 328 8 HET L2P A 333 18 HET SQU A 341 11 HET SQU A 342 8 HET SQU A 343 8 HETNAM RET RETINAL HETNAM L2P 2,3-DI-PHYTANYL-GLYCEROL HETNAM SQU 2,10,23-TRIMETHYL-TETRACOSANE HETSYN L2P 1,2-DI-1-(3,7,11,15-TETRAMETHYL-HEXADECANE)-SN-GLYCEROL HETSYN SQU LIPID FRAGMENT FORMUL 2 RET C20 H28 O FORMUL 3 L2P 14(C43 H88 O3) FORMUL 8 SQU 4(C27 H56) FORMUL 21 HOH *58(H2 O) HELIX 1 AA1 GLU A 9 GLY A 31 1 23 HELIX 2 AA2 ASP A 36 LEU A 62 1 27 HELIX 3 AA3 TRP A 80 VAL A 101 1 22 HELIX 4 AA4 ASP A 104 THR A 128 1 25 HELIX 5 AA5 VAL A 130 GLY A 155 1 26 HELIX 6 AA6 ARG A 164 GLY A 192 1 29 HELIX 7 AA7 PRO A 200 ARG A 225 1 26 HELIX 8 AA8 SER A 226 PHE A 230 5 5 SHEET 1 AA1 2 LEU A 66 PHE A 71 0 SHEET 2 AA1 2 GLU A 74 TYR A 79 -1 O ILE A 78 N THR A 67 LINK NZ LYS A 216 C15 RET A 301 1555 1555 1.35 CRYST1 60.570 60.570 110.890 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016510 0.009532 0.000000 0.00000 SCALE2 0.000000 0.019064 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009018 0.00000